Categories of adherence of the arMED scorea | arMED score, continuous | |||
---|---|---|---|---|
Low | Medium | High | 3-units increase | |
Overall mortality | ||||
All BC survivorsb | 1.13 (1.01–1.26) | 1.00 reference | 0.94 (0.84–1.05) | 0.92 (0.87–0.97) |
N (deaths) | 3427 (736) | 5162 (871) | 4681 (733) | 13,270 (2340) |
Premenopausal BC survivorsc,d | 1.21 (0.94–1.56) | 1.00 reference | 1.11 (0.89–1.38) | 0.94 (0.84–1.06) |
N (deaths) | 613 (131) | 1152 (183) | 1305 (213) | 3070 (527) |
Postmenopausal BC survivorsc,e | 1.10 (0.98–1.24) | 1.00 reference | 0.89 (0.78–1.01) | 0.92 (0.86–0.98) |
N (deaths) | 2814 (605) | 4010 (688) | 3376 (520) | 10,200 (1813) |
P value heterogeneity* | 0.437 | |||
BC-specific mortality | ||||
All BC survivorsb | 1.12 (0.98–1.29) | 1.00 reference | 0.99 (0.86–1.13) | 0.97 (0.90–1.04) |
N (deaths) | 3427 (441) | 5162 (541) | 4681 (493) | 13,270 (1475) |
Premenopausal BC survivorsc,d | 1.23 (0.92–1.63) | 1.00 reference | 1.16 (0.91–1.48) | 0.97 (0.85–1.11) |
N (deaths) | 613 (103) | 1152 (145) | 1305 (180) | 3070 (428) |
Postmenopausal BC survivorse | 1.10 (0.94–1.28) | 1.00 reference | 0.93 (0.78–1.09) | 0.97 (0.89–1.05) |
N (deaths) | 2814 (338) | 4010 (396) | 3376 (313) | 10,200 (1047) |
P value heterogeneity* | 0.992 |